CompaniesOnconic Therapeutics

Onconic Therapeutics

active
Seoul, Korea
Founded 2020
Website
About

Small Molecules

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (14)
View all

Total Trials

14

As Lead Sponsor

13

As Collaborator

1

Total Enrollment

1,970

By Phase

PHASE3: 4PHASE1: 7PHASE2: 3

By Status

COMPLETED: 9RECRUITING: 3NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04335604
NCT05257993
NCT05475184
NCT06502743
NCT06439563
Hover over trial bars to see details

Recent Trials

NCT07160790Lead Sponsor
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
PHASE3Not yet recruiting
321 participants
Started: Sep 2, 2025 · Completed: Jun 30, 2026
NCT07181538Lead Sponsor
Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers
PHASE1Completed
55 participants
Started: Feb 4, 2025 · Completed: Mar 5, 2025
NCT06439563Lead Sponsor
Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers
PHASE3Recruiting
364 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2027
NCT06502743Collaborator
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer
PHASE2Recruiting
92 participants
Started: Sep 12, 2024 · Completed: Dec 31, 2027
NCT05712681Lead Sponsor
Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers
PHASE1Completed
24 participants
Started: Mar 29, 2023 · Completed: May 18, 2023
View all 14 trials →
Locations (1)
Headquarters
Seoul, Korea
Map

Loading map...